+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Proton therapy in adjuvant treatment of gastric cancer: planning comparison with advanced x-ray therapy and feasibility report



Proton therapy in adjuvant treatment of gastric cancer: planning comparison with advanced x-ray therapy and feasibility report



Acta Oncologica 53(10): 1312-1320



Adjuvant chemoradiotherapy improves both overall- and relapse-free survival in patients with resected gastric cancer. However, this comes at the cost of increased treatment-related toxicity. Proton therapy (PT) has distinct dosimetric characteristics that may reduce dose to normal tissues, improving the therapeutic ratio. The purpose of this treatment planning study is to compare PT and intensity-modulated x-ray therapy (IMXT) in gastric cancer with regards to normal tissue sparing. The patient population consisted of resected gastric cancer patients treated at a single institution between 2008 and 2013. Patients who had undergone 4D CT simulation were replanned to the originally delivered doses (45-54 Gy in 25-30 daily fractions) using six-field photon IMXT and 2-3-field PT (double scattering-uniform scanning techniques). Thirteen patients were eligible for the planning comparison. IMXT provided slightly higher homogeneity indices (median values 0.04 ± 0.01 vs. 0.07 ± 0.01, p = 0.03). PT resulted in significantly (p < 0.05) lower intermediate-low doses for all the normal tissues examined (small bowel V15 82 ml vs. 133 ml, liver mean doses Gy 11.9 vs. 14.4 Gy, left/right kidney mean doses 5/0.9 Gy vs. 7.8/3.1 Gy, heart mean doses 7.4 Gy vs. 9.5 Gy). The total energy deposited outside the target volume was significantly lower with PT (median integral dose 90.1 J vs. 129 J). Four patients were treated with PT: treatment was feasible and verifications scans showed that target coverage was robust. PT can contribute to normal tissue sparing in the adjuvant treatment of gastric cancer, with a potential benefit in terms of compliance to treatment, acute and late toxicities.

(PDF emailed within 0-6 h: $19.90)

Accession: 055260533

Download citation: RISBibTeXText

PMID: 24797885

DOI: 10.3109/0284186X.2014.912351


Related references

Regarding "a treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours". RadioTherapy and Oncology 63(2): 231-231, 2002

A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours. Radiotherapy and Oncology 61(3): 287-297, 2001

Pencil beam scanning proton therapy vs rotational arc radiation therapy: A treatment planning comparison for postoperative oropharyngeal cancer. Medical Dosimetry 42(1): 7-11, 2016

A treatment planning comparison of volumetric modulated arc therapy and proton therapy for a sample of breast cancer patients treated with post-mastectomy radiotherapy. Journal of Proton Therapy 1(1), 2015

Adjuvant radiation therapy for early stage seminoma: proton versus photon planning comparison and modeling of second cancer risk. RadioTherapy and Oncology 103(1): 12-17, 2012

Comparative treatment planning between proton and X-ray therapy in locally advanced rectal cancer. Radiotherapy & Oncology. 41(3): 263-272, 1996

Postoperative adjuvant chemotherapy using NCS (neocarzinostatin) and 5-FU in the treatment of gastric cancer. First report--A comparison with the 5-year survival rate of patients undergoing combined therapy with MMC and 5-FU. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(11): 3064-3070, 1987

A treatment planning study of proton arc therapy for para-aortic lymph node tumors: dosimetric evaluation of conventional proton therapy, proton arc therapy, and intensity modulated radiotherapy. Radiation Oncology 11(1): 140, 2016

Evaluation of effective neo-adjuvant chemotherapy (FLEP therapy) in the treatment of advanced gastric cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(11): 1748-1752, 1991

Advanced radiation therapy technologies in the treatment of rectal and anal cancer: intensity-modulated photon therapy and proton therapy. Clinical Colorectal Cancer 6(5): 348-356, 2007

Intensity Modulated Radiation Therapy With S-1 Versus Capecitabine as Adjuvant Treatment for Locally Advanced Gastric Cancer. International Journal of Radiation Oncology*biology*physics 93(3): E133-E134, 2015

Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapy. Gynecologic Oncology 94(1): 61-66, 2004

Helical tomotherapy and intensity modulated proton therapy in the treatment of early stage prostate cancer: a treatment planning comparison. RadioTherapy and Oncology 98(1): 74-80, 2011

A treatment planning comparison between proton beam therapy and intensity-modulated x-ray therapy for recurrent nasopharyngeal carcinoma. Journal of X-Ray Science and Technology 18(4): 443-450, 2011

A Phase I Study of Concurrent Capecitabine and Intensity Modulated Radiation Therapy(IMRT) as Adjuvant Treatment for Locally Advanced Gastric Cancer. International Journal of Radiation Oncology*biology*physics 84(3): S315-S316, 2012